Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
about
Innate function of house dust mite allergens: robust enzymatic degradation of extracellular matrix at elevated pH7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinaeGenome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis.Canine epidermal lipid sampling by skin scrub revealed variations between different body sites and normal and atopic dogsReview: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.The Microbiome: The Trillions of Microorganisms That Maintain Health and Cause Disease in Humans and Companion Animals.Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis.Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity.Immune responses in dogs with cutaneous adverse food reactions.Epidemiology of human atopic dermatitis--seven areas of notable progress and seven areas of notable ignorance.The genomics revolution: will canine atopic dermatitis be predictable and preventable?Advancements in the maintenance of skin barrier/skin lipid composition and the involvement of metabolic enzymes.The regulatory role of the tetrapeptide AcSDKP in skin and hair physiology and the prevention of ageing effects in these tissues--a potential cosmetic role.Fixing the skin barrier: past, present and future--man and dog compared.Histologic morphology and involucrin, filaggrin, and keratin expression in normal canine skin from dogs of different breeds and coat types.Pilot study to evaluate the effect of topical dimethicone on clinical signs and skin barrier function in dogs with naturally occurring atopic dermatitis.The effect of long-term feeding of skin barrier-fortified diets on the owner-assessed incidence of atopic dermatitis symptoms in Labrador retrievers.Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.Atopic dermatitis and the intestinal microbiota in humans and dogs.Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.Plasma and skin vitamin E concentrations in canine atopic dermatitis.Investigation of the effect of probiotic exposure on filaggrin expression in an experimental model of canine atopic dermatitis.Expression patterns of superficial epidermal adhesion molecules in an experimental dog model of acute atopic dermatitis skin lesions.Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dIncreased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.Gastrointestinal hemodynamics in dogs with nonfood induced atopic dermatitis.Nucleophosmin modulates the alleviation of atopic dermatitis caused by the marine-derived compound dihydroaustrasulfone alcohol.Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.Dermatophagoides farinae house dust mite allergen challenges reduce stratum corneum ceramides in an experimental dog model of acute atopic dermatitisAtopic dermatitis in cats and dogs: a difficult disease for animals and ownersCD4+and CD8+skin-associated T lymphocytes in canine atopic dermatitis produce interleukin-13, interleukin-22 and interferon-γ and contain a CD25+FoxP3+subsetAnti-Atopic Properties of Gracillin Isolated from on 2,4-Dinitrochlorobenzene-Induced Skin Lesions in MiceGuidelines for Symptomatic Medical Treatment of Canine Atopic Dermatitis
P2860
Q33868196-91FA8DEE-D048-4754-9D35-4CF95940ED5DQ34109984-E99E105E-7637-4E5A-A570-E1B7329A65BDQ34351982-DBC14B88-C46B-40B9-910A-C540EFDBCD86Q34720303-44DAAB3F-178D-4C6C-BC3A-D7EC8A7FCA84Q35205061-A90CE204-1E4A-4261-A464-79ACDABDA997Q35561749-894E8834-53FC-41F6-B4A3-F864DDB2CC4CQ35721841-D948F3B2-1AEF-4ABD-9AA0-DF59EF6EE8EEQ36110782-EB45796E-87DA-4F0D-B120-1D3BBE3FD1FAQ36958942-03496208-A859-481D-9565-51791D83BE0AQ38003687-C06B07E2-6EB3-4636-BFCB-6A0DA979C5ABQ38032611-C9BEF4BF-2A6E-4F59-81E1-D5F211881627Q38075144-DA566F84-A681-4E3D-990F-7FAEBF5F0EBFQ38075145-C90313F7-4285-4376-B428-321602B191A5Q38894252-DBAB24EA-53BC-472A-8BCB-24A4ABA85602Q39181396-16220776-F619-4D2E-8282-1E74E847196DQ39482750-7278A9DB-8ACF-48C5-AB9E-9749F5776FC5Q40042057-1F71048D-BA98-426A-8208-5A7C661863A1Q40713129-B77C6620-7835-45B1-AC0C-7EA64DAA9D07Q41834886-5D3F23FC-CB10-4421-8FD5-8558160E7C9AQ41953638-9BA3B82C-F345-4F8E-8ED6-C7ABA8AD449CQ42647813-925ADA16-578D-4D11-85FA-048F926201E2Q42682689-42838CC4-037F-4B2D-9729-8A4AE486E76CQ43469926-F42DB946-76C8-4F65-92DC-46FA850BA15CQ43503624-19AF1562-4F9E-4FBC-9479-7A007DA344E2Q43539502-7DA941A6-0176-4918-9E9F-EAA70DC05C06Q44876764-A1BAD9A6-907D-4004-AD4C-123CFE087643Q47959934-E1BCDD7A-670C-488B-B9D1-080D2CB9F43AQ50739047-E9354381-F956-44CF-8D6B-18C94206B096Q51342312-3D220FCE-59C8-41B3-8163-55223F481951Q52367519-B856E6C3-4941-4122-BD11-1FC7E174F24FQ53200680-1231AAFA-C2F2-470F-A204-355A5C0762B6Q57429826-47336F0D-64D5-44B4-A4E4-A44D4FACD193Q57482859-0898115D-1C7D-4C6A-AF7F-E66051DEB5CDQ58243597-E6C7992B-BFA8-46E9-B47C-6E4A4A13BBA1Q58773250-C90ECA9B-7B77-4851-BFBF-ACCF9C2E76D0Q58796340-C3E175B7-4568-4687-BDA5-C9D047920E81
P2860
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@en
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@nl
type
label
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@en
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@nl
prefLabel
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@en
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@nl
P2093
P2860
P1476
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
@en
P2093
Didier-Noel Carlotti
International Task Force on Canine Atopic Dermatitis
Rosanna Marsella
Thierry Olivry
P2860
P304
P356
10.1111/J.1365-3164.2011.00967.X
P577
2011-03-17T00:00:00Z